has server used (United States) ping response time Hosted in Cloudflare, Inc. Register Domain Names at Key-Systems GmbH. This domain has been created 5 years, 285 days ago, remaining 79 days. You can check the 7 Websites and blacklist ip address on this server

Domain information

Registrar WHOIS Server:

Registrar URL:     See All 64,185+

Creation Date: 2016-04-08 5 years, 285 days

Updated Date: 2021-03-07 317 days ago

Expiry Date: 2022-04-08 79 days left     See All

  Sign up for notifications near expiration

Registrar: Key-Systems GmbH

Abuse Email: [email protected]

Abuse Phone: +49.68949396850

  Full details

Top 10 Hosting Providers

Registrar URLDomain CountsRegistrar NameAbuse Email,280,, LLC[email protected]
www.tucows.com535,579Tucows Domains Inc.
networksolutions.com526,027Network Solutions, LLC[email protected]
www.namecheap.com333,839NameCheap, Inc.[email protected]
www.enom.com299,925eNom, LLC
www.publicdomainregistry.com294,948PDR Ltd. d/b/a[email protected],, LLC[email protected]
www.fastdomain.com161,753FastDomain Inc.[email protected]
www.ionos.com159,2071&1 IONOS SE[email protected]
www.networksolutions.com149,653Network Solutions, LLC[email protected]

Full view & Download

Keywords Suggestions


Erleada medication

Erleada side effects

Erleada prescribing information

Erleada cost

Erleada pi

Erleada 60 mg

Erleada chemo

Erleada indication

Erleada price

Erleada apalutamide

Erleada dosage

Erleada package insert

Erleada side effects in men

Erleada generic

Erleada smpc

Erleada fachinformation

Erleada erfahrungen

Erleada compendium

Erleada duration of therapy

( Please select at least 2 keywords )

See More:   A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z  

› Side effects for erleada

› Erleada patient reviews

› Erleada fda label

› Erleada vs xtandi

› Erleada price

› Erleada pi

› Erleada chemo

› Erleada indications

Hosting Provider


Organization: Cloudflare, Inc.     See All 637,900+

Provider URL:


IP Server: Reg: 2014-03-28, Updated: 2021-05-26

Blacklist: Check Backlist Status

Country: United States

Address: 101 Townsend Street, San Francisco, CA 94107, US

Latitude: 37.750999

Longitude: -97.821999

Name Server:


Abuse Email: [email protected]

Abuse Phone: +1-650-319-8930

Top 10 Hosting Providers

Website URLDomain CountsOrganizationAbuse Email
Google.com681,421Google LLC[email protected]
Godaddy.com650,, LLC[email protected]
Cloudflare.com637,900Cloudflare, Inc.[email protected]
Endurance.com488,827The Endurance International Group, Inc.[email protected]
Amazon.com439,891Amazon Technologies Inc.[email protected]
297,405Domain Name Services
Amazonaws.com287,121Amazon Technologies Inc.[email protected]
Liquidweb.com159,971Liquid Web, L.L.C[email protected]
Squarespace.com150,667Squarespace, Inc.[email protected]
Ripe.net128,362RIPE Network Coordination Centre[email protected]

Full view & Download

List of found email addresses

No Emails Found

Find Websites hosted



3: Changed to:

4: Changed to:



7: Changed to:

At least 7 Sites on this server

Port Scanner (IP:

Homepage ERLEADA® (apalutamide) HCP

  • Effect of ERLEADA ® on Other Drugs
  • CYP3A4, CYP2C9, CYP2C19, and UGT Substrates — ERLEADA ® is a strong inducer of CYP3A4 and CYP2C19, and a weak inducer of CYP2C9 in humans
  • Concomitant use of ERLEADA ® with medications that are primarily metabolized by CYP3A4, CYP2C19, or CYP2C9 can result in lower exposure to these medications   DA: 18 PA: 18 MOZ Rank: 36

Get Help Paying For ERLEADA® ERLEADA® (apalutamide)

ERLEADA ® (apalutamide) is a prescription medicine used for the treatment of prostate cancer: that has spread to other parts of the body and still responds to a medical or surgical treatment that lowers testosterone,   DA: 15 PA: 19 MOZ Rank: 35

Side Effects ERLEADA® (apalutamide)

  • ERLEADA ® may cause fertility problems in males, which may affect the ability to father children
  • Talk to your healthcare provider if you have concerns about fertility
  • Do not donate sperm during treatment with ERLEADA ® and for 3 months after the last dose of ERLEADA ®.
  • Tell your healthcare provider if you have any side effect that bothers you or that does not go away.   DA: 15 PA: 27 MOZ Rank: 44

Erleada (Apalutamide)

  • To receive farther information about Erleada and its effects, talk to your doctor.As the fastest growing pharmacy program in the country, Prescription Hope can obtain Erleada for individuals at the set cost of $50.00 per month
  • To obtain prescription medications, Prescription Hope works directly with over 180 pharmaceutical manufacturers   DA: 20 PA: 9 MOZ Rank: 32

Welcome To Janssen Edify

{api:media-embed{MjYsImZpbGVfZmllbGRfaW1hZ2UiLHsic2V0dGluZ3MiOnsiaW1hZ2Vfc3R5bGUiOiIiLCJpbWFnZV9saW5rIjoiIn19}/} …   DA: 20 PA: 20 MOZ Rank: 44

Specialty Pharmacy Information For ERLEADA® (apalutamide)

  • the ERLEADA® network due to their geographic coverage, payer coverage, and ability to fulfill and dispense oral oncolytics
  • Specialty pharmacies may offer services to verify insurance coverage, identify potential patient assistance programs, and   DA: 23 PA: 50 MOZ Rank: 78

ERLEADA Prices & Free Savings Vouchers Near Me

  • ERLEADA and other branded drugs often have a generic equivalent on the market at a significantly lower price
  • Generics account for around 8 out of 10 prescriptions filled in the US and are identical their brand name counterparts in quality, safety, strength, dosage form, route of administration, performance characteristics and intended use.   DA: 15 PA: 8 MOZ Rank: 29

Dosing And Adminstration ERLEADA® (apalutamide) HCP

  • Effect of ERLEADA ® on Other Drugs
  • CYP3A4, CYP2C9, CYP2C19, and UGT Substrates — ERLEADA ® is a strong inducer of CYP3A4 and CYP2C19, and a weak inducer of CYP2C9 in humans
  • Concomitant use of ERLEADA ® with medications that are primarily metabolized by CYP3A4, CYP2C19, or CYP2C9 can result in lower exposure to these medications   DA: 18 PA: 40 MOZ Rank: 65

Erleada: Side Effects, Cost, Dosage, Uses, And More

  • Erleada (apalutimide) is a brand-name prescription drug that's used to treat certain forms of prostate cancer
  • Learn about side effects, cost, and more.   DA: 24 PA: 16 MOZ Rank: 48

Erleada (apalutamide): Side Effects, Dosage & Uses

  • What is Erleada? Erleada (apalutamide) is an anti-androgen
  • It works in the body by preventing the actions of androgens (male hormones)
  • Erleada is used to treat prostate cancer that has spread to other parts of the body (metastatic) and is also being treated with another medicine or with surgery.   DA: 13 PA: 13 MOZ Rank: 35

Erleada Medicare Coverage And Co-Pay Details

  • In the Deductible stage, you may be responsible for the full cost of your drug
  • After your deductible has been satisfied, you will enter the Post-Deductible (also called Initial Coverage) stage, where you pay your copay and your plan covers the rest of the drug cost.   DA: 14 PA: 26 MOZ Rank: 50


  • Aspecto de Erleada y contenido del envase
  • Erleada comprimidos recubiertos con película son comprimidos recubiertos con película de ligeramente amarillentos a verdes grisáceos, forma oblonga (16,7 mm de largo por 8,7 mm de ancho), con “AR 60” grabado en una de las caras
  • Los comprimidos se pueden presentar en un frasco o en un estuche.   DA: 13 PA: 44 MOZ Rank: 68

Erleada Prices, Coupons & Savings Tips

  • About GoodRx Prices and Erleada Coupons GoodRx‘s cash prices are based on multiple sources, including published price lists, purchases, claims records, and data provided by pharmacies
  • Most of our discount and coupon prices are based on contracts between a pharmacy (or pharmacy purchasing group) and a Pharmacy Benefit Manager (PBM), who   DA: 14 PA: 8 MOZ Rank: 34

Erleada Side Effects: Common, Severe, Long Term

  • provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products
  • This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment
  • Data sources include IBM Watson Micromedex (updated 6 Dec 2021), Cerner Multum™ (updated 1 …   DA: 13 PA: 30 MOZ Rank: 56

Erleada Jan 2021

  • You are invited to hear Jonathan Henderson, MD, Lawrence Karsh, MD, and Gordon A
  • Brown, DO, discuss Erleada for the treatment of advanced prostate cancer (mCSPC and nmCRPC)
  • The live presentations will be held three times on Thursday, January 21, 2021 and will not be available on demand later.   DA: 13 PA: 17 MOZ Rank: 44

Drug Trial Snapshot: Erleada FDA

ERLEADA+ADT (N=806) Placebo+ADT (N=401) ERLEADA+ADT Placebo+ADT; Metastasis Free Survival: 184 (23%) 194 (48%) 40.51 (NE, NE) 16.20 (14.59, 18.40) 0.28 (0.23, 0.35) Time to Metastasis: 175 (22%   DA: 11 PA: 50 MOZ Rank: 76

Erleada Oral: Uses, Side Effects, Interactions, Pictures

Find patient medical information for Erleada oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.   DA: 13 PA: 41 MOZ Rank: 70

Erleada Erleada Coupons And Discounts $49 NiceRx

  • Erleada costs without insurance will vary depending on how much you buy and the retailer you buy it from
  • As a guide, Erleada tablets 60 mg will typically cost around $13,500 for 120 tablets
  • If you obtain your medication through NiceRx, you will pay a flat monthly rate of $49 per medication regardless of its retail price.   DA: 14 PA: 21 MOZ Rank: 52

Erleada (apalutamide) Dose, Indications, Adverse Effects

  • If concomitant use is unavoidable, increase the dose of erlotinib in 50 mg increments at 2-week intervals as tolerated (maximum dose, 450 mg)
  • Erlotinib is a CYP3A4 substrate and apalutamide is a strong CYP3A4 inducer
  • Coadministration with another strong CYP3A4 inducer decreased erlotinib exposure by 58% to 80%.   DA: 11 PA: 39 MOZ Rank: 68

Patients Getting Placebo Allowed To Cross To Erleada As

  • Erleada (apalutamide) is an androgen receptor inhibitor indicated for the treatment of patients with non-metastatic castration-resistant prostate cancer
  • It became the first treatment to receive FDA approval for this disease state on Feb   DA: 16 PA: 30 MOZ Rank: 65

EROAD USA Fleet Management Solutions & Tracking Systems

  • EROAD gives you accurate, consistent data to drive your business
  • We put easy-to-use tools in your drivers’ hands that they can trust to make them productive, safe and happy
  • And we give you the support you need on the road and in the office to keep processes, people and loads moving, turning complex fleet data into better fleet performance.   DA: 13 PA: 13 MOZ Rank: 46

Janssen Announces Treatment With Apalutamide Significantly

  • With nearly four years of median follow-up, data from the final analysis of the Phase 3 TITAN study confirmed that ERLEADA ® plus ADT provided a statistically significant improvement in OS with a 35 percent reduction in risk of death versus ADT alone (HR 0.65; p<0.0001)
  • 1 The results were similar to the primary analysis of TITAN despite the   DA: 16 PA: 50 MOZ Rank: 87

Erleada Approved For Metastatic Castration-Sensitive

Erleada, an androgen receptor inhibitor, is already indicated for the treatment of non-metastatic, castration-resistant prostate cancer.It is …   DA: 12 PA: 50 MOZ Rank: 84

ERLEADA Dosage & Rx Info Uses, Side Effects

  • ERLEADA prescription and dosage sizes information for physicians and healthcare professionals
  • Pharmacology, adverse reactions, warnings and side effects.   DA: 12 PA: 14 MOZ Rank: 49

ERLEADA® (apalutamide) Oral Presentations Demonstrate

ERLEADA ® is an androgen receptor inhibitor indicated for the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC) and for the treatment of patients with   DA: 27 PA: 50 MOZ Rank: 26

J&J Puts Pressure On Rivals With New Erleada Okay In

  • The FDA based the new indication on results of the phase 3 TITAN study, which included 1,052 patients and compared Erleada to placebo given on top of ADT
  • The study found that Erleada reduced the risk of death by 33% compared to the control group
  • Two-year overall survival (OS) rates were 84% and 78%, respectively.   DA: 14 PA: 50 MOZ Rank: 89

ERLEADA® (apalutamide) Oral Presentations Demonstrate

Post-hoc analysis shows that ERLEADA ® provides rapid, deep, and durable PSA declines in advanced prostate cancer, with depth and speed of response correlating to improved overall survival Real-world data demonstrate that, across racial groups, patients prescribed ERLEADA ® for non-metastatic castration-resistant prostate cancer stay on therapy San Francisco, CA …   DA: 16 PA: 50 MOZ Rank: 92

Janssen Submits SNDA To FDA For Erleada In Prostate Cancer

  • Inside information on cancer research and drug development   DA: 16 PA: 31 MOZ Rank: 74

Erleada Gains First Approval Under New TGA Work Sharing

  • Erleada was also evaluated using TGA’s priority review pathway, which was initiated in June 2017 to formalize expedited reviews of drugs for patients with unmet needs and serious conditions
  • Janssen’s drug was approved in the US in February as the first treatment for non-metastatic prostate cancer.   DA: 12 PA: 50 MOZ Rank: 90

Health Canada Approves ERLEADA™* (apalutamide Tablets

ERLEADA™ decreased the risk of metastasis or death in patients by 70 per cent and improved median metastasis-free survival by more than two years 1 TORONTO, July 4, 2018 /CNW/ - The Janssen   DA: 27 PA: 50 MOZ Rank: 21

Recently Analyzed

1: 5 seconds ago

2: 1 seconds ago

3: 5 seconds ago

4: 2 seconds ago

5: 6 seconds ago

6: 0 seconds ago

7: 2 seconds ago

8: 2 seconds ago

9: 3 seconds ago

10: 3 seconds ago

Tool Checker

Domain Expiry Date Updated

Expiry DateExpiry DateDomain ProviderHosting Provider
Fandom.com1 year, 263 days leftTucows Domains Inc.Fastly 158 days left1&1 IONOS SELiquid Web, L.L.C
Motivelinks.com1 year, 10 days, LLCMicrosoft Corporation 243 days,, LLC 118 days, LLCCenturyLink Communications, LLC 341 days, LLCAmazon Technologies Inc. 211 days leftNameCheap, Inc.Contabo Inc. 194 days leftDreamHost, LLCDigitalOcean, LLC 79 days leftKey-Systems GmbHCloudflare, Inc. 273 days leftNameScout Corp.NCS Technologies

<< See All >>

.COM - 10,595,200+   .ORG - 1,117,549+   .EDU - 123,500+   .NET - 792,945+   .GOV - 30,232+   .US - 84,439+   .CA - 122,904+   .DE - 220,061+   .UK - 272,390+   .IT - 108,882+   .AU - 152,812+   .CO - 51,739+   .BIZ - 59,081+   .IO - 32,494+   .NL - 99,647+   .SG - 19,713+   .INFO - 81,589+   .IE - 26,934+   .ME - 25,076+   .FR - 98,576+   .EU - 61,372+   .RU - 165,043+   .PH - 9,511+   .INT - 1,166+   .IN - 87,021+   .ES - 38,035+   .CZ - 71,869+   .VN - 48,920+   .TV - 14,250+   .SITE - 9,829+   .RO - 37,484+   .PL - 44,520+   .PK - 10,373+   .MOBI - 4,464+   .LK - 5,507+   .CN - 66,137+   .CH - 66,914+   .AT - 31,992+  

Email Address Search | IP Address Blacklist Check | Hosting Providers | Domain Providers | Website Error Checker

© 2018 All rights reserved. Email: [email protected]